Skip to content

Testing the Safety of Bumsuit Baby Products for Skin Irritation and Allergies in Healthy Children

A Non Randomized, Open Label, Single Center Study to Evaluate the Irritation and Sensitization Potential of Baby Products in Healthy Volunteer Children using Primary Irritation Test. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080659
Enrollment
24
Registered
2025-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Kamson Healthcare Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy volunteers aged 5 to 18 years. 2. Subjects with no clinically significant dermatological conditions e.g., eczema, psoriasis. 3. Subjects whose guardians/parents have provided Informed Consent. 4. Willing to adhere to study restrictions no use of other skincare products in the test area.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Measurement of local skin reactions such as erythema (redness), edema (swelling), dryness, or scaling at the application site after 24 hours. These will be scored using a standard irritation scoring scale.Timepoint: Day 0, Day 1, Day 2, Day 3 and Day 7

Secondary

MeasureTime frame
Observation of any signs of allergic sensitization, such as delayed erythema, papules, or vesicles, occurring post-24-hour patch removal and in subsequent follow-ups. Sensitization will be scored and categorized based on the intensity of reactions.Timepoint: Day 0, Day 1, Day 2, Day 3 and Day 7

Countries

India

Contacts

Public ContactMs Arpita Malgi

Samahitha Research Solutions

satyalm@samahitha.com9739001749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026